Jounce Therapeutics Stock
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Sign up today and learn more about Jounce Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Jounce Therapeutics Stock
Director of Business Development and Operations
Thomas F. Gajewski
Robert I. Tepper
Interim Chief Technology Officer
Vice President of Research